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Abstract
Bariatric surgery results in significant weight loss in the majority of patients living with severe 
obesity (BMI≥35kg/m2). Improvement in Health Related Quality of Life (HRQoL) is an equally 
important patient reported outcome; however, there are few studies reporting the impact of 
bariatric surgery on long-term (≥5 years) HRQoL outcomes. The main aim of this thesis was 
two-fold: first to conduct a SR in order to assess the quality of evidence and effectiveness of 
bariatric surgery on HRQoL ≥ 5 years in patients ≥18 years compared to non-surgical control 
groups and second to conduct a meta-analysis (MA) of studies that have been deemed 
appropriate. 
PubMed, Cochrane Review, EmBase, CINANL, PsycInfo, obesity conference abstracts, and 
reference lists of published papers were searched. Keywords were bariatric surgery, obesity, and 
quality of life. Studies were included if (1) there was ≥5 years follow-up, (2) patients had class II
or III obesity, (3) individuals completed a validated HRQoL survey, and (4) there was a non-
surgical comparison group with obesity. Two reviewers independently assessed each study. 
From the initial 1376 articles, 9 studies were included in the SR and 6 in the MA. 
Inconsistent results for long-term improvements in physical and mental health emerged from the 
SR. However, in contrast, the MA found significant improvements in these domains ≥5 years 
after bariatric surgery. These study findings provide evidence for a substantial and significant 
improvement in physical and mental health favoring the surgical group compared with controls 
spanning 5 to 25 years after surgery, an important finding for patients, clinicians and decision-
makers. 
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Chapter 1  Introduction
1.1 Background and Rationale
1.1.1 Epidemiology of Obesity 
The increasing prevalence of obesity is a global health problem. Obesity, most often defined 
as a body mass index or BMI≥ 30kg/m2 (1), is associated with several comorbid conditions. 
Obesity can be divided into classes that indicate the associated health risks that are linked to 
excess body weight. Class I is defined as BMI=30-34.9kg/m2, Class II is BMI=35-39.9 kg/m2 
and Class III is BMI≥40 kg/m 2 (1,2). Class II and III are associated with increased morbidity, 
higher risk of death and a greater burden on the healthcare system (3-5). Class II and III obesity, 
commonly referred to as severe obesity, are associated with an even greater risk of developing 
comorbid conditions that include but are not limited to: insulin resistance and type 2 diabetes 
mellitus, cardiovascular disease, stroke, hypertension, dyslipidemia, sleep apnea, gallbladder 
disease, gout, osteoarthritis and a variety of cancers (1).  In addition, severe obesity impairs health
related quality of life (HRQoL) and shortens life expectancy (1, 5, 6). The combination of comorbid 
conditions and their associated burdens have the greatest impact on a person living with severe 
obesity. In Canada, as in many other countries, severe obesity (BMI≥35kg/m2) has increased. It 
now affects 5% of the population or an estimated 1.2 million adults and it is projected to increase
to 6.4% by 2019 (7).
1.1.2 Health Related Quality of Life 
 HRQoL encompasses measures of well-being and physical and psychosocial functioning. It 
measures a patient’s self reported state of physical, social and psychosocial well-being (8) As with
many chronic conditions or illnesses, the change in a patient’s condition can be measured by 
various evaluations or end points such as changes in disease severity and improvement or 
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resolution of associated comorbidities or mortality, but these outcome measures are not reported 
by patients and do not always reflect treatment success that is meaningful to patients. This 
dissonance between patients and practitioners has led to the development of a quantifiable 
method for measuring patient HRQoL.  Often administered in the form of a questionnaire or 
survey, HRQoL can be measured and quantified, which is useful for researchers and clinicians to
better understand patients’ perceptions of what matters most to them in terms of their quality of 
life. Being able to quantify HRQoL has helped researchers to evaluate changes in HRQoL before
and after an intervention. 
A number of tools have been developed and validated to measure HRQoL domains (e.g., 
mobility, pain, anxiety, usual activities). These tools can be specific to a condition such as 
measuring HRQoL associated with obesity, CVD, COPD and cancer or more generic by 
measuring HRQoL in general either in a population with a diseases or a broader general 
population. It is also important to measure the HRQoL of the general population in order to 
obtain population normative data; so that comparisons can be made with diseased-populations in 
order to better understand the impact of disease on HRQoL. The HRQoL of those living with 
obesity is often measured by both generic and specific (to obesity) validated tools. The most 
common generic tools include the EQ-5D and the SF-36 or one of its shortened versions such as 
the SF-12. Specific tools include the Impact of Weight on Quality of Life; BAROS (bariatric 
surgery specific) and Obesity Problems Scale (OPS).    
 The EQ-5D-3L(9) is an indirect preference-based health survey that consists of 5 dimensions 
assessing mobility, self care, pain, usual activity and anxiety, each of which is rated on one of 
three levels; no problems, some problems or extreme problems. This combines to create 243 
possible health states. The descriptive system is then scored using a set of weights that describe 
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the general population’s preferences and from this a single summary preference based utility 
index or score is calculated.  The utility scores range between 1 and -0.59, with 1 representing 
full health where the respondent has no problems for any dimension and -0.59 representing that 
the respondent has reported the lowest level for each dimension(9). A visual analogue scale 
(VAS) is also calculated which shows an overall health score for the EQ-5L respondents. The 
VAS ranges from 0 to 100 representing worst imaginable health and perfect health respectively. 
The results are presented as a mean and standard deviation(9).  
The SF-12v2 (version 2) is a shortened version of the Short-Form 36 (SF-36) which is a 
common generic health status tool. The SF-12 has been validated against the SF-36 for patients 
with and without obesity(10). The survey has 12 questions that examine 8 different quality of life 
domains: physical function, role physical, bodily pain, general health, vitality, social function, 
role emotional and mental health. Overall physical and mental component scores (MCS) are then
calculated from these domains(11).  
The IWQoL-Lite is the shortened form of the Impact of Weight on Quality of Life (IWQoL). 
This validated survey specifically assesses the impact of obesity on the quality of life in 
individuals seeking weight loss treatment and is the first survey of its kind to do so(12). The 
IWQoL-Lite incorporates 31 statements that begin with the phrase “Because of my weight…” 
and each statement provides 5 response options from (1) “Never true” to (5) “Always true”. 
These measure the impact of weight on 5 different domains: physical function, self-esteem, 
sexual life, public distress and work life. Each domain has an associated score calculated for 
each patient as long as they have answered at least 50% of the questions in that domain.  An 
overall score is calculated if patients have responded to at least 26 of 31 questions. The raw 
scores are converted into a T-score (0-100) with 0 representing worst possible health and 100 
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representing best possible health. Results are reported as mean and standard deviation for each 
domain and total score(12).
1.1.3 Severe Obesity and Health Related Quality of Life  
Severe obesity has been linked to a significantly lowered HRQoL (13-17). Many studies 
demonstrate a significant link between increasing BMI and a deterioration in HRQoL (13, 15-17). 
In the systematic review (SR) and meta-analysis (MA) conducted by Van Nunen et al(13), patients
with obesity that were actively seeking surgical treatment showed the most reduced HRQoL 
when compared to both a general populations and other obese non-surgical treatment seeking 
populations using measures from the IWQoL (measured in mean deviation in standard deviation 
units from the norm, -5.5 < d < -2.8)(13) . The same SR and MA looked at studies using the SF-36
survey and found that while there were differences in results when compared to the IWQoL 
results, the group seeking surgical treatment still had the worst reported HRQoL (measured in 
mean deviation and in standard deviation units from the norm, -1.6 < d < -0.5)(13). The SF-36 
results showed a significant decrease in HRQoL in 5 of 8 physical domains and 2 mental 
domains. The authors suggest that these results indicate that impaired HRQoL and limitations in 
daily life in severely obese patients are not solely determined by excess weight (13). This helps to 
highlight the validity of the SF-36 as a partly weight independent outcome measure for HRQoL. 
The results of these studies also suggest that a decrease in physical function may be a reason why
patients seek out surgical treatment more than other obese patients that have similar BMIs. (13) .  
Herpertz et al. (14) conducted a SR that focuses on whether bariatric surgery increases 
psychosocial functioning.  In this review,  40 studies were reviewed with follow up times 
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ranging from 12-185 months. Various types of bariatric surgery and a variety of tools were used 
to measure psychosocial functioning. 
When examining populations at baseline, studies have demonstrated that treatment 
seeking populations have higher levels of anxiety and depression as well as decreased self 
esteem before surgery  versus after (14,18) . 
One study of patients examined a list of 187 HRQoL items that were then ranked by 100 
patients who were classified as severely obese (BMI≥40kg/m2) (15). These items were categorized
and given a clinical impact score which was determined by the important score reported by 
patients and the proportion of patients who deemed it important. The most important domains 
were identified as: activity and mobility, symptoms, personal hygiene/clothing, emotions, social 
interactions, sexual life, and eating behaviour. These represented the most severely impacted 
HRQoL items for the patients (15). This study showed that the impact of severe obesity is not 
limited to activity/mobility. Severe obesity contributes to the impairment of many different areas 
in HRQoL(15).
Two other studies(16,17) focus on the impact of severe obesity on HRQoL. Jia and Lubetkin
(16) studied a range of different US populations and administered the SF-12 and EQ-5D surveys. 
Fontaine et al. (17) compared different classes of obese patients using the SF-36 survey.  Using a 
multivariate linear regression, Jia and Lubetkin (16) found that when compared to a normal 
population, the severely obese population had the largest decrements in the SF-12  physical 
component scores (PCS) (4.00), EQ-5D index (0.073) and EQ VAS (4.68) scores. They also 
found a smaller but still significant decrement in SF-12 MCS (1.07) (16). The study also showed 
an inverse relationship with BMI and HRQoL scores. This effect is seen both with and without 
obesity-related comorbid conditions (16).  Both studies found that physical domain scores were 
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more greatly impacted in the severely obese populations compared to normal and other 
overweight and obese populations (16,17). Results for Fontaine et al. (17) also demonstrate that the 
bodily pain score of the SF-36 is significantly more impaired (P< 0.005) and to a greater degree 
in severely obese patients (mean bodily pain score 52.8 ±26.5) than those with the chronic 
conditions such as depression (58.8± 26.7), HIV (59.1 ±23.2) or congestive heart failure (62.2 
±30.9)(17) .  
In summary, HRQoL is significantly impaired in severely obese populations.  Studies 
demonstrate an inverse relationship between HRQoL and BMI and it appears that severe obesity 
impacts more than just the physical domains or weight-related domains of HRQoL such as 
mobility. A reduction in HRQol in the severely obesity cannot be explained by excess weight or 
comorbid conditions alone. 
1.1.4 Bariatric Surgery as a Treatment for Severe Obesity 
Severe obesity is challenging to treat. “Standard” weight loss methods including lifestyle 
changes that focus on exercise and changes in diet or counseling or behaviour modifications, 
medical management and pharmaceutical solutions have limited effectiveness either on 
significant weight loss or sustained weight loss in the long term. These approaches to weight loss
result in an average weight loss of 5-10% of initial body weight. This is modest weight loss and 
although it can often improve a patient’s comorbid profile, it is often not enough to result in 
significantly improved quality of life(19-22). The most effective treatment for severe obesity is 
bariatric surgery which results in significant and sustained weight loss, improvement in 
comorbid conditions, improved quality of life in the short term and a reduction in the risk of 
death (23-31). In Canada, the clinical practice guidelines recommend surgical treatment for adults 
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living with severe obesity. Patients must have a BMI≥35kg/m2 including an obesity-related 
comorbidity (e.g., diabetes, hypertension, sleep apnea) or a BMI≥40kg/m2 (3). 
There are different types of bariatric surgery, but all types are categorized as 
malabsorptive, restrictive or a combination of both (3,28-31). Malabsorptive procedures limit caloric 
and nutrient absorption in the digestive tract. An example is the biliopancreatic 
diversion/duodenal switch (BPD/OS) in which part of the small intestine is removed or rerouted 
to avoid nutrient and calorie uptake. Restrictive procedures physically limit the amount of food 
that can be consumed. The gastric volume is reduced either through surgically removing a 
portion of the stomach (laparoscopic sleeve gastrectomy or LSG) or by banding with a device 
that can be inflated to restrict the volume of the stomach (adjustable gastric banding or AGB). 
The current gold standard for bariatric surgery is the roux-en-y gastric bypass (RYGB) which is 
a combination of both a restrictive and malabsorptive procedure as it reduces the size of the 
gastric pouch as well as re-routing a portion of the intestinal tract(29).   
In the past 10-15 years there has been a shift in the type and volume of bariatric surgery 
performed (32,33). In 2003, 146,301 bariatric surgeries were performed globally and in 2013 that 
number grew to 468,609, with the majority of surgeries performed in the United States and 
Canada(33). The type of surgery performed has also changed over time. In 2003, 85% were 
RYGB, 9% AGB and 4.5% BPD/DS. In 2013 the percentages were 45.0% RYGB, 37.0% LSG, 
10% AGB and 1.5% BPD/DS(33). This trend shows exponential growth in LSG in the United 
States and Canada as well as globally (33). The increase in laparoscopic surgeries makes clinical 
sense as these procedures are minimally invasive and reduce surgical risk, hospital stay and 
recovery time compared to open techniques. These reasons have all contributed to the increasing 
popularity of this procedure(34). 
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Bariatric surgery is associated with a decreased rate of mortality when compared to non-
surgical treatments for obesity(24-26, 35-37). A MA comparing non-surgical interventions and 
bariatric surgery reported that bariatric surgery when compared to controls reduced the risk of 
global mortality (OR = 0.55, CI, 0.49–0.63), cardiovascular mortality (OR = 0.58, CI, 0.46–
0.73), and all cause mortality (OR 0.70, CI, 0.59–0.84) through a reduction of myocardial 
infarction, diabetes, and cancer-related deaths(35). A reduction in mortality post-surgery has been 
reported in several studies in different countries (24, 36, 37). The results from the Swedish Obesity 
Study (SOS) (24) show that after 15 years follow-up, the surgical group had a hazard ratio of 0.76 
(95%CI, 0.59 to 0.99; P=0.04), compared with the control group that used conventional weight 
loss methods. Over the follow-up period,129 subjects (6.3%) in the control group died, while 101
(5.0%) of the surgical group died. Adams et el.(36) found a reduction in all-cause mortality after 
7.1 years of follow-up in a surgical group as compared to an obese population group (37.6 vs. 
57.1 deaths per 10,000 person-years, P<0.001) (36). Peeters et al.(37) report that their surgical group
had a 72% lower hazard of death compared to the control population group (HR 0.28; 95% CI 
0.1-0.85) after a median follow up time of 4 years. 
1.1.5 Bariatric Surgery as a Treatment for Severe Obesity and its Impact on 
HRQoL 
There is substantial evidence to suggest that bariatric surgery for the treatment of severe 
obesity improves HRQoL in patients’ post-surgery compared to severely obese groups either 
waiting for surgery or not seeking treatment in the short term(27, 38). The SOS (27) reports the 
largest improvement in HRQoL at 1 year post surgery. In the short term, significant 
improvements have been reported post-surgery for general health, physical HRQoL (e.g., 
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mobility, pain, usual activities) and weight-specific HRQoL with significant but less impact on 
mental or emotional health (27, 38).
The short term results are mixed on the type and magnitude of the association between 
the  degree of weight loss and degree of HRQoL improvement. The first 6-18 months is the peak 
time for weight loss post bariatric surgery  (25). A inverse association between the amount of 
excess weight lost and an improvement in HRQoL has been reported showing the peak weight 
loss and the largest improvement on several HRQoL surveys at 2 years post-surgery (27). In 
contrast, another study reports that the degree of body mass reduction does not influence the 
degree of HRQoL improvement(39). However this study also found that the surgical population 
showed positive HRQoL results that exceeded those of the general population at one year post 
surgery. A recent SR also reported that out of 24 studies with varying follow-up time intervals  
most treatment seeking populations demonstrated a significant improvement in HRQoL at 1 year
post surgery(40). 
 There are very few studies that report on HRQoL 5 years or greater post-surgery, but in
general in those that do, the authors suggest that bariatric surgery is associated with greater 
improvements in both general and obesity specific measures of HRQoL between six to ten years 
after surgery when compared to non-surgical care(27, 41, 42). However, the differences in association
with weight loss and HRQoL also necessitate a need for long term results as weight loss is 
known to slow down or reverse in the long-term post bariatric surgery(27).  
1.1.6 Gaps in the Literature 
Little is known about the impact of bariatric surgery on HRQoL in patients in the long 
term (≥ 5 years) post bariatric surgery(43). Study results are often limited to assessing physical 
quality of life with less focus and reporting of mental and emotional quality of life(41). A recent 
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study has shown that bariatric surgery results in a greater improvement in physical HRQoL than 
in mental health scores (44). In the long term, at least one study demonstrates that post- surgery 
HRQoL varies and is  dependent on the maintenance of weight loss(27). Given the increasing 
number of bariatric surgeries being performed, it is important to know if improved HRQoL 
scores observed in the early stages post bariatric surgery are maintained over time. 
1.2 Purpose of Study 
The overall purpose of the current study was to examine the impact of bariatric surgery as a 
treatment for severe obesity on long term (≥ 5years) HRQoL in patients who have undergone 
bariatric surgery.
1.3 Significance of the Study
Severe obesity significantly impairs HRQoL, and although bariatric surgery results in 
significant weight loss in the majority of patients, there is far less known about its impact over 
the long term ( ≥ 5 years), an equally important outcome for patients. Although a short term 
study has assessed the impact of bariatric surgery on HRQoL and have reported physical and 
mental health improvements(45), very few studies report longer term outcomes, and of those 
published there are inconsistent results in physical and mental health(27, 41,46-53).   
Severe obesity is increasing disproportionately in Canada and many other countries (7,54, 55-57), 
and in response so is the number of bariatric surgeries performed(33). It is increasingly important 
to determine the effectiveness of surgery not only on weight loss and clinical outcomes but on 
patient reported outcomes such as HRQoL 
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1.4 Specific Research Objectives
The specific research objectives of the current study are:
1. to develop a protocol and search strategy focused on conducting a SR 
2. to assess the quality of evidence and effectiveness of bariatric surgery on the long term (≥
5 years) HRQoL of patients (≥18 years) compared to non-surgical controls that include 
patients living with severe obesity not seeking treatment or those patients waiting for 
surgery, and  
3. to conduct a MA of appropriate studies to examine the impact of bariatric surgery on 
mental and physical health domains, if feasible.    
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Chapter 2 Protocol  
2.1 Unpublished A Priori Protocol for Bariatric Surgery and its Impact on Quality of 
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Dr. Laurie Twells  
Dr. John Fardy
Dr. Deborah Gregory
Funding Sources/Sponsors: Healthcare Foundation, Eastern Health 
2.1.1 Introduction
The World Health Organization has acknowledged the prevalence of obesity as a 
worldwide epidemic (1, 2). The WHO defines overweight and obesity as “abnormal or excessive 
fat accumulation that presents a risk to health” (2). Overweight and obesity are commonly 
measured using the BMI calculated from weight in kilograms divided by height in metres 
squared (kg/m2). Overweight is considered to be a BMI≥25kg/m2 and obesity is considered to be 
a BMI≥30kg/m2 (2, 3). Obesity is something that affects both men and women and is prevalent in 
adult and child/adolescent populations. It has been suggested that obesity is caused by the 
imbalance between high energy intake generally associated with fat and carbohydrate rich diets, 
a sedentary lifestyle that translates to low energy expenditure and in some cases a level of 
genetic susceptibility that leads to obesity (1, 4). Excessive fat is associated with a range of serious 
non-communicable disease including diabetes mellitus, various cardiovascular diseases, 
musculoskeletal disorders, some cancers and others that lead to premature mortality(2). Along 
with these comorbidities, there is a reduction in HRQoL (1, 5). 
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Bariatric surgery has proved to be the only most effective treatment for obesity and is 
associated with significant and sustained weight loss (6). Most bariatric surgeries are performed 
on patients who are considered severely obese and have been assessed by a team of medical 
professionals. Severe obesity is defined as having a BMI≥40kg/m2 or a BMI≥35kg/m2 with at 
least one comorbid condition (1, 7). The ideal bariatric surgery patients also have the following 
characteristics (7): acceptable operative risk, documentation of failure with non-surgical weight-
loss programs, thorough understanding of procedures, realistic expectations and well-informed 
and motivated patients. 
Bariatric surgery can be restrictive, mal-absorptive or a combination of the two. In 
restrictive surgeries, the size of the stomach is reduced to limit food intake and slow down the 
digestive process. Mal-absorptive procedures normally reduce the exposure of food to the 
intestine which limits the amount of calories absorbed by the body. This is achieved through by-
passing or removal of parts of the intestine.  Procedures that use a combination of the two 
methods both restrict the stomach size as well as remove or by-pass portions of the intestine (8). 
The gold standard of bariatric surgeries has been the Roux-en-y gastric bypass (RYGB) 
surgery (7, 9). In a RYGB, the stomach is reduced to a small pouch and attached directly to the 
jejunum, bypassing the duodenum completely. It produces weight loss by both restricting the 
ability to consume large amounts of food as well as by being a mal-absorptive procedure through
a reduced small intestine (7). 
Another common procedure is the laparoscopic adjustable gastric band. In this procedure 
an inflatable device is placed around the top portion of the stomach to reduce the size and slow 
the intake of food.  It is a restrictive, minimally invasive procedure (8-10).
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The sleeve gastrectomy has recently increased in popularity as a bariatric procedure. In 
this procedure, the stomach is surgically reduced to a sleeve-like tube by removing around 80% 
of the stomach. In this procedure, the intestinal pathway stays intact (8, 9, 11).
 Regardless of what type of bariatric surgery is used, there are various benefits and 
complications associated with each. Surgeries can be either “open” or “laparoscopic”.  Open 
surgeries are associated with more complications post-surgery as they are more invasive 
procedures. While laparoscopic surgeries are less invasive, it is not always a suitable procedure 
for patients that are too obese or have had previous abdominal surgeries (12, 13). 
The primary outcome of bariatric surgeries for obesity is weight loss. The largest weight 
loss period post-surgery is the first 6-12 months. After this period, there is a tapering off of 
weight loss and in some cases weight regain occurs (7, 8, 10). The resolution of co-morbidities is 
also an important outcome of bariatric surgery.  There is also general improvement of mobility, 
which in turn can help with increased overall fitness levels and in maintaining weight loss (6-9).  
HRQoL measurements encompass measurements of well-being, functioning and health 
under physical, social and psycho-social domains or categories (14). The HRQoL scores are most 
often recorded through a variety of questionnaires, each having their own strengths and areas of 
focus. There are general and specific quality of life measurements. General surveys are designed 
to assess to general well-being and can be administered to a variety of populations.  Disease 
specific surveys relate directly to a certain disease or condition, obesity or excess weight in this 
case, that may impact quality of life.
2.1.2 Study Measurement Tools
The Newfoundland and Labrador Bariatric Surgery Cohort Study (NL BaSCo Study) 
uses a combination of 3 validated HRQoL measurements to assess enrolled patients. They are the
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SF-12v2 (adapted from the Short Form 36 tool), the Impact of Weight on Quality of Life-Lite 
(IQWOL-Lite) and the European Quality of Life-5 dimensions-3Level (EQ-5D-3L). The 
instruments are described below.
The SF-12 (Adapted from the SF-36 tool) (15) is a validated questionnaire that has been well 
established to reflect patient’s overall health. The survey is short to complete and gives an 
overall view of the health status of the patient. The survey has 12 questions that examine 8 
different quality of life domains: physical function, role physical, bodily pain, general health, 
vitality, social function, role emotional and mental health. 
The EQ-5D-3L(16) is a generic measure of health and is useful for population health 
surveys as well as clinical and economic healthcare evaluations. The survey is scored on 5 
dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. These 
are then ranked at 3 levels: no, some or extreme problems. The responses are pooled and 
represented on a visual analog scale ranging from ‘Worst imaginable health state” to “best 
imaginable health state”. This is a single-index value that can be used as a quantitative measure 
of health judged by the individual patient. 
The IWQOL-Lite assesses a patient’s perception on how their weight affects their daily 
life. It is comprised of 31 questions/items and is divided into 5 scales: physical function, self-
esteem, sexual life, public distress and work. Each item begins with the phrase: “Because of my 
weight…” and patients have 5 response options from 1 = never true to 5 = always true. 
It has been used in bariatric surgery patient populations (17, 18). 
There is variation in the maintenance of weight loss in long term post- operative results. 
Quality of life outcomes are less studied and it is important to know if the improved scores seen 
in early stages post-bariatric surgery are maintained over time. Improvements in HRQoL have 
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become an important outcome of these surgeries. Since HRQoL is a secondary outcome for 
bariatric surgery, the reporting is often sporadic, and a wide variety of measurements that are not 
always validated are used. A recent study has shown that weight loss shows a greater 
improvement in physical HRQoL than in mental scores (17). Theses findings may be attributed to 
the use of specific versus generic tools that may result in significant differences in the HRQoL 
scores recorded. Second, the type of study may also affect the amount of HRQoL improvement 
seen. For example, a randomized control trial is much stricter in inclusion and exclusion criteria 
than an observational study. For these reasons the HRQoL changes seen in an RCT may not 
accurately reflect real world results. 
This SR will pool the results of both randomized control trials and observational studies 
to compare generic and specific tools, mental and physical scores and summary component 
scores. 
2.1.3 Reason for a Systematic Review
An SR of the literature will help assess the overall impact of bariatric surgery on quality 
of life in obese patients. If possible, a MA of validated questionnaires will be performed to 
analyze the pooled results. While there have been some general reviews of the literature, and at 
least one SR looking at the effects of a variety of weight loss methods on HRQoL (19), to our 
knowledge there are no previously published SRs addressing this question.  This review will 
compare specific and generic tools, mental and physical components in randomized control trials
and observational studies. 
Review Objective:
To assess the impact of bariatric surgery for obesity on quality of life in adults 18 and 
older. 
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Types of study to be included: 
(1) Randomised controlled trials (RCTs) (published or unpublished).
(2) Non-randomised studies (NRS; concurrent and non-concurrent cohort studies)
Participants/Population: adults (age 18+) who have undergone bariatric surgery for the treatment 
of either class II (with at least one comorbid condition) or class III obesity.
Intervention/exposure: Bariatric surgery AND participate in a general or weight specific 
measurement of QOL. 
Comparator/Control: obese population/wait listed patients or pre-surgery results.
Primary Outcomes (At the time of protocol submission –May 2014): 
• Measures of quality of life 
Secondary Outcomes:
• Weight loss
• Resolution of comorbid conditions
• Surgical complications
Electronic Searches 
PubMed, Embase, CINAHL, PsycINFO
MeSH : bariatric surgery, quality of life
The search strategy will be designed with the assistance of a medical librarian and 
approved by the members of the research team before starting. Articles will be filtered by age for
18+. There will be no language or publication date restrictions. Reference lists of included 
studies and any relevant SRs identified will also be searched.
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Searching Other Resources 
Authors of major papers/studies will be contacted to see if there is any unpublished 
material or additional conference or abstract reports. Grey material will be searched for bariatric 
surgery abstracts and surgery protocols. Major conference meeting notes will also be searched. 
These include the Canadian Obesity Conference, European Congress on Obesity and The 
Obesity Society (TOS) Annual Scientific Meeting. Reference lists of included papers will be 
thoroughly searched for any additional studies missed in the preliminary searches. 
2.1.4 Study Selection and Data Extraction
One reviewer (SD) will perform a preliminary search using the search strategy approved 
by other members of the research team. After the preliminary search, two reviewers (SD,LT) will
independently scan study titles, abstracts, and keywords of every non-duplicate record retrieved 
from the literature search. Irrelevant titles will be excluded and full-text papers will be obtained 
where titles are deemed to be relevant or where eligibility is unclear. A record of why each study
is rejected will be kept to include in the final SR for the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) flowchart and ‘characteristics of excluded studies’ chart.
Two independent reviewers will identify studies using a study eligibility/relevance form. 
Discrepancies will be resolved by consensus. Where pertinent information is missing, authors of 
the papers will be contacted for the additional information.  Following identification of the 
included studies, each reviewer will independently extract relevant study data. Relevant missing 
data will be obtained from authors, if feasible. Where discrepancies arise, consensus will be 
reached, and a third reviewer will adjudicate if necessary. References found from online 
databases will be managed and stored using RefWorks. 
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Data extraction will follow the altered Cochrane Public Health Group data extraction forms. 
From each paper outcomes involving weight/BMI, comorbid conditions and HRQoL will be 
recorded as well as population demographics for both intervention and control/comparison 
groups.
2.1.5 Risk of Bias Assessment
Two reviewers will assess the risk of bias or ‘quality’ of each study. Randomized control 
trials will be assessed using the ‘The Cochrane Collaboration’s tool for assessing risk of bias’ 
Observational studies will be assessed using the Newcastle-Ottawa Scale for assessing the 
quality of nonrandomized studies. Each reviewer will make notes on hard copies of the papers 
with the reasoning for their quality assessment scores to be included in the SR. 
2.1.6 Measure of Treatment Effect
Standardized mean differences will be used where possible as studies may use different 
HRQoL tools. Weight loss and resolution of co-morbidities will be reported as changes from 
mean scores. 
2.1.7 Strategy for Data Synthesis
Results between studies will be compared by study design (RCT versus observational), 
physical versus mental components and specific versus generic tools. The results will include a 
summary of findings table including the outcomes for each study on HRQoL, weight loss, and 
reduction in co-morbidities. The table will also include the type of surgery, number of 
participants in each study and the quality of the study.
Assessment of Heterogeneity
The I2 statistic will be used to quantify the level of heterogeneity. 
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2.2  Complete Search Strategy
PubMED/MEDLINE (834)
1) "Bariatric Surgery"[Mesh]  OR “bariatric surgery” [Title/Abstract]
2)  “gastrectomy”[mesh] OR  gastrectomy [Title/Abstract]
3) #1 OR #2  
4) "Obesity"[Mesh] OR obesity [Title/Abstract]
5) “Morbid Obesity” [Mesh] OR “Morbid Obesity” [Title/Abstract]
6) #4 or #5
7) “Quality of Life”[Mesh] OR “Quality of life” [Title/Abstract]
8) “psychometrics”[mesh] OR psychometrics [Title/Abstract]
9) "health-related quality of life” [Title/Abstract]
10) "Short-Form" OR "Short Form"  SF36 OR “SF-36” OR SF12 OR “SF-12”  OR “SF-6D” 
OR SF6D 
11) EQ-5D OR "Euroqol*" OR “visual analogue scale” 
12) “health state preference”
13) "BAROS" 
14) “obesity and weight loss quality of life” OR OWLQOL 
15)  #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 
16) #3 AND #5 AND #16
Embase (691)
1) 'bariatric surgery'/exp OR "Bariatric Surgery":ti,ab
2) 'gastrectomy'/exp OR "gastrectomy":ti,ab
3) 'stomach bypass'/exp OR 'gastric bypass':ab,ti
4) 'roux y anastomosis'/exp OR 'roux en y':ab,ti
5) #1 OR #2 OR #3 OR #4
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6) 'obesity'/exp OR 'obesity':ab,ti
7) 'morbid obesity'/exp OR 'morbid obesity':ab,ti
8) #6 OR #7
9) 'quality of life'/exp OR 'quality of life':ab,ti
10) 'psychometry'/exp OR 'psychometry':ab,ti
11) 'eq 5d' OR 'euroqol' OR 'visual analogue scale'
12) OR 'health state preference'
13) 'baros'
14) 'obesity and weight loss quality of life' OR owlqol
15) #9 OR #10 OR #11 OR #12 OR #13 OR #14 
16) #5 AND #8 AND #16
17) #17 AND ([adolescent]/lim OR [adult]/lim OR [aged]/lim OR [middle aged]/lim OR 
[young adult]/lim)
CINAHL (148)
1) (MH "Bariatric Surgery+") OR (MH "Bariatric Patients")OR TI "bariatric surgery" AND 
AB "bariatric surgery" 
2) (MH "Gastrectomy") OR TI "gastrectomy" OR AB gastrectomy 
3) (MM "Gastric Bypass") OR  TI gastric bypass OR AB gastric bypass
4) (MM “Anamastosis, Roux-en-Y”) OR TI roux en y OR AB roux en y
5) #1 OR #2 OR #3 OR #4
6) (MM "Obesity+") OR (MM "Obesity, Morbid")
7) TI ( obesity OR "morbid obesity" ) OR AB ( obesity OR "morbid obesity" ) 
8) #6 OR #7
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9) (MM "Quality of Life+") OR TI "Quality of Life" OR AB "Quality of Life"
10) (MM "Psychometrics") OR TI “Psychometrics” OR AB “Psychometrics”
11) (MM "Short Form-36 Health Survey (SF-36)") OR TI Short Form-36 (SF-36) OR AB 
Short Form-36  (SF-36) OR TI “short-form 12”OR SF-12 OR AB “short-form 12”OR 
SF-12
12) TX "eurqol" OR TX eq5d OR TX "visual analogue scale" 
13) TX ("health state preference" ) 
14) TX BAROS
15) TX 'obesity and weight loss quality of life' OR owlqol
16) #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 
17) #5 AND #8 AND #17
PsycInfo (95)
1) Bariatric surgery AND Obesity AND  Quality of life
Cochrane Review (132)
1) "Bariatric Surgery"[Mesh]  OR “bariatric surgery” [Title/Abstract]
2)  “gastrectomy”[mesh] OR  gastrectomy [Title/Abstract]
3) #1 OR #2  
4) "Obesity"[Mesh] OR obesity [Title/Abstract]
5) “Morbid Obesity” [Mesh] OR “Morbid Obesity” [Title/Abstract]
6) “Quality of Life”[Mesh] OR “Quality of life” [Title/Abstract]
7) “psychometrics”[mesh] OR psychometrics [Title/Abstract]
8) "health-related quality of life” [Title/Abstract]
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9) "Short-Form" OR "Short Form"  SF36 OR “SF-36” OR SF12 OR “SF-12”  OR “SF-6D” 
OR SF6D 
10) EQ-5D OR "Euroqol*" OR “visual analogue scale” 
11)  “health state preference”
12) "BAROS" 
13) “obesity and weight loss quality of life” OR OWLQOL 
14) # 6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14
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3.1 Introduction  
Bariatric surgery is considered to be the only treatment for severe obesity that results in 
significant weight loss (1). Individuals are eligible for bariatric surgery if they have a 
BMI≥40kg/m2 or a BMI≥35kg/m2 with at least one obesity-related comorbidity (2, 3). Impaired 
quality of life is common in bariatric surgery candidates and is often one of the motivating 
factors for seeking surgery. Along with weight loss and resolving co-morbidities, improving 
HRQoL is an important outcome. HRQoL encompasses measures of well-being, functioning and 
health under physical, social and psycho-social domains (4). 
Short to mid-term (<5 years) HRQoL results post-surgery are well documented and show 
a significant improvement in physical health scores often reaching population normative values(5-
9). However, after this “honeymoon” period, there can be a plateau or weight recidivism (10). 
Longer-term HRQoL data are scarce and in the published studies available limitations noted 
include: selective reporting, non- standardized presentation of results, use of non-validated 
measurement tools, and reporting of HRQoL as a secondary outcome with incomplete and 
inconsistent data. The long-term impact of bariatric surgery on HRQoL is unknown (11,-14).
Studies have shown a greater improvement in physical HRQoL than in mental health scores as 
these domains more directly benefit by a reduction in body weight (15). The mental health 
outcomes are inconsistent (11, 16-24). There have been general reviews published and at least one SR
examined the effects of a variety of weight loss methods on HRQoL(25), but to our knowledge 
there is only one previously published SR addressing long term (i.e., ≥ 5years) HRQoL after 
bariatric surgery(24). In that SR, the authors found that HRQoL after bariatric surgery improved 
significantly in the short term, declined slightly after 2 years and appeared to stabilize 5 years 
post-operatively. The authors included long-term, prospective studies, however not all studies 
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used a control or comparator group and some used a normal weight comparator while others 
used baseline results.  There was no MA performed because the authors considered it 
inappropriate due to heterogeneity. The aim of our study was to conduct a SR of studies 
reporting health-related quality life data at least five years after bariatric surgery in patients 18 
years of age and older and in non-surgical obese comparison control groups.  An MA of the 
HRQoL results was planned if deemed appropriate. 
3.2 Methods  
3.2.1 Search Strategy
Eligibility criteria for studies included patients 18 or older who received bariatric surgery 
(type of surgery was not limited) for severe obesity defined as a BMI≥35kg/m2 with a 
comorbidity or a BMI≥40kg/m2 (2). For a study to be included in the review, a non-surgical obese 
comparison group with similar demographics to the surgical group at baseline had to be 
available. Follow-up time post-surgery was at least 5 years. The completion of a validated 
HRQoL survey at follow up was required. There were no publication type or publication date 
restrictions. In the protocol the plan was to include all languages. Once the initial searches were 
conducted, the articles that came back in other languages were available in English or did not 
meet the other study criteria based on the results. Therefore the language of study was limited to 
English. The study type was not limited and reviews including SRs were included in the search. 
The initial search strategy was designed with the assistance of a medical librarian and 
approved by members of the research team. Keywords were formatted for each search engine. 
PubMed, Cochrane Review, EmBase, CINAHL and PsycInfo were searched.  The Medical 
Search headings (MeSH) used were: “bariatric surgery”, “gastrectomy”, “obesity” “morbid 
obesity”, “quality of life” and “psychometrics”. Each of these was also searched as a keyword in 
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[ti] and [ab] so as not to miss un-indexed articles. In addition to the MeSH terms, the following 
quality of life questionnaires were also included: health-related quality of life, "Short-Form" or 
“Short Form", “SF36”,“SF-36”, SF12 ,“SF-12”,“SF-6D”, “SF6D”, “EQ-5D”,"Euroqol", “visual 
analogue scale”, “health state preference”, “BAROS" ,“obesity and weight loss quality of life”, 
“OWLQOL” . It was decided after the initial search was completed to exclude studies that used 
surveys measuring only one aspect of quality of life such as depression or anxiety, and studies 
that used BAROS as it was applicable to the surgical treatment group only following surgery. 
For the current review, HRQoL surveys were included that assessed both physical and mental 
domains. In the protocol, the intent was to combine the results from a variety of HRQoL tools, 
but the differences in scales and presentation of results made the standardization of the means 
not possible. This is why the SF-36 survey was chosen after completing the search as there were 
the largest number of papers using this tool that fit all the other selection criteria. For this reason 
standardized mean difference was not used for the results as it was only the one survey type used
and the results  were all measured on a uniform scale. The full search strategy for each electronic
database has been described in Chapter 2.  Major conference meeting notes were searched. These
included the Canadian Obesity Summit, European Congress on Obesity and The Obesity Society 
(TOS) Annual Scientific Meeting. Reference lists of included papers were examined for 
additional studies missed in preliminary searches. Authors of papers were contacted for missing 
data, where possible. All references were managed and stored using RefWorks (26).
The final search was conducted on June 15th, 2015. The search yielded the following 
papers from online databases: PubMed (892), Cochrane Review (147), EmBase (762), CINAHL 
(168), PsycInfo (115).  After duplicates were removed, 1376 references were identified from 
searching electronic and alternative sources. Upon reviewing titles and abstracts, 1355 were 
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removed for not having adequate follow-up, inadequate comparison groups, if they were 
commentaries/editorials, comparing different bariatric procedures, using an invalidated HRQoL 
tool, being published in a language other than English and for not meeting patient inclusion 
criteria. The remaining 21 articles were read in full text. Of these, 12 were excluded: due to the 
HRQoL tool used (i.e., not the SF-36) (n=3), non-surgical weight loss procedure (n=1), 
inadequate follow-up time (n=3), studies not published in English (n=3), no comparison group 
(n=2). 
3.2.2 Risk of Bias (Quality) Assessment
One reviewer (SD) performed a preliminary search using the approved search strategy. 
After the preliminary search, one reviewer (SD) scanned study titles, abstracts, and keywords of 
every non-duplicate record retrieved from the literature search. Irrelevant titles were excluded 
and full-text papers were obtained where titles were deemed to be relevant or where eligibility 
was unclear. Two reviewers (SD and LT) independently assessed the remaining full text articles 
for eligibility criteria as well as risk of bias using the US Preventative Task Force quality rating 
criteria for assessing the quality of nonrandomized studies (27). 
3.2.3 The US Preventative Task Force (USPSTF) Quality Criteria Rating
When assessing any type of scientific study, there must be both external and internal 
validity. External validity is the extent to which the evidence is relevant and generalizable to the 
population under study. Individual studies can increase their external validity by using 
randomized sampling methods and ensuring that the study population accurately reflects the 
larger population it is trying to reflect. Internal validity is the degree to which the study provides 
valid or accurate evidence for the population and setting in which it was conducted. The US 
Preventative Services Task Force (UPSTF) represents the efforts of the government and other 
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organizations committed to the development of clinical practice guidelines through a more 
evidence based approach. The USPSTF has developed an objective system for assessing the 
internal validity of various types of scientific studies (27). This system uses quality criteria 
checklists used to assess the quality of SRs, case-control studies, randomized control trials 
(RCT), cohort studies, and diagnostic accuracy studies. The current SR included cross-sectional 
studies, cohort studies and one prospective controlled trial. For this reason, the criteria checklists 
used for RCT’s and cohort studies was the most appropriate to assess the internal validity of the 
studies. The checklist contains 8 categories each of which is given a poor, fair or good rating as 
well as an overall rating. The categories are described below:   
● Initial assembly of comparable groups: For cohort studies: consideration of potential 
confounders with either restriction or measurement for adjustment in the analysis; consideration 
of inception cohorts 
● Maintenance of comparable groups (includes attrition, crossovers, adherence, contamination) 
● Important differential loss to follow-up or overall high loss to follow-up 
● Measurements: equal, reliable, and valid (includes masking of outcome assessment) 
● Clear definition of interventions
● All important outcomes considered 
● Analysis: adjustment for potential confounders for cohort studies
Each reviewer reads the study and independently awards a ranking for each paper in each
category. Studies are given a rating of good, fair or poor. Studies given a “good” rating meet the 
following criteria: comparable groups are assembled initially and maintained throughout the 
study (including follow-up at least 80 percent); reliable and valid measurement instruments are 
used and applied equally to the groups; interventions are spelled out clearly; important outcomes 
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are considered; and appropriate attention to confounders in analysis. Studies are graded a “fair” 
rating if any or all of the following problems occur, without the important limitations noted in 
the “poor” category below: comparable groups are assembled initially but some question remains
whether some (although not major) differences occurred in follow-up; measurement instruments 
are acceptable (although not the best) and generally applied equally; some but not all important 
outcomes are considered; and some but not all potential confounders are accounted for. Studies 
will be graded as “poor” if any of the following major limitations exists: groups assembled 
initially are not close to being comparable or maintained throughout the study; unreliable or 
invalid measurement instruments are used or not applied at all equally among groups (including 
not masking outcome assessment); and key confounders are given little or no attention(27).
Only papers that receive an overall ranking of “fair” or “good” are included. Papers that 
receive an overall “poor” rating are excluded for further review.  Using the quality criteria 
ratings helps to increase the likelihood that only papers with low systematic error are included 
which make the results of a SR and MA more accurate. 
In the current study, the two reviewers (SD, LT) discussed any discrepancies and a 
consensus on quality was reached for each paper. The level of inter-rater agreement was 100%. 
Following identification of the included studies, each reviewer independently extracted relevant 
study data. Study location, surgery type, study population age, number of participants in both 
groups, BMI at baseline (where provided) and follow up, time to follow up, and quality of life 
survey used were extracted from each paper. Where feasible, missing data was obtained from 
authors through email correspondence.
3.2.4 Meta-analysis 
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All MAs were performed using Review Manager v. 5.3(28). Results were entered as mean 
domain score with standard deviation for the surgical and comparison group at time of long-term
follow up. In the current study, HRQoL scores in patients ≥ 5 years post surgery were compared 
with baseline scores of a non-surgical control group (i.e., eligible patients waiting for bariatric 
surgery or those seeking treatment). This approach was based on our hypothesis that the 
intervention would result in significant improvements in HRQoL in the long-term compared with
those who were not exposed to the intervention. 
Three studies used multiple comparison groups. For the purpose of the MA, one group 
was selected for comparison. For Kolotkin et al. (18) and Raoof et al. (23), the wait-listed 
populations were chosen as they were similar to the other comparison groups in the selected 
studies. In the case of Våge et al. (21), the group with the smaller population was chosen as it had a
small surgical group and the smaller comparison was less likely to skew the results than the 
second comparison group which had over a thousand individuals. To be analyzed in the MA the 
SF-36(29) results had to be entered in the same format of mean domain score and standard 
deviation. Authors were contacted by email if the data were published in a different format. 
Kolotkin et al. (18), and Aftab et al. (22), responded with the data from their respective studies in the
desired format. In other cases (19, 21), the results were converted from the format given into the 
desired format of mean and standard deviation. Vȧge et al.2003 provided the mean and 95% CIs 
converted to a standard deviation. Laurino Neto & Herbella (19) provided the median score an IQR
which were changed to mean and standard deviation using: (lower limit of IQR+ 2(median) + 
upper limit of IQR)/4 with a sample size ≥ 25. When results were provided in a different format 
in a study they were either (a) converted using a similar approach as that used by Laurino Neto &
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Herbella(19) i.e., the conversion of IQR/median to mean with standard deviation, or (b) entered as 
the mean at follow up if available from the authors upon request. 
3.2.5 Data Analysis for Meta-analysis 
In the current MA, the random effects model was chosen to analyze the results. Under the
random effects model, the assumption is that differences between studies are not all the same but
that they do follow some sort of similar distribution. This model incorporates the lack of 
knowing why there are real or potential differences in the treatment effect by treating them all as 
random (30). The statistics used to measure heterogeneity were Χ2, I2 and Tau2.  The Χ2 examines if
observed result differences are congruent with chance alone. A large Χ2 statistic relative to its 
degrees of freedom gives evidence of heterogeneity of intervention effects (31). The I2 describes 
the percentage of variability in effect estimates that is due to heterogeneity rather than chance (31).
The I2 results can sometimes be misleading as it is a calculated value that depends on several 
factors. In general:  0% to 40%: might not be important; 30% to 60%: may represent moderate 
heterogeneity; 50% to 90%: may represent substantial heterogeneity; 75% to 100%: may 
represent considerable heterogeneity(31). The Tau2 is an estimate of between study variance for a 
random-effects model (31). If Tau2 > 1 it is likely there is substantial heterogeneity. This MA 
includes studies with small populations as well as non-randomized groups which can influence 
the heterogeneity. Since statistical heterogeneity may differ, for these reasons, it is also important
to present results of each study within a forest plot in order to visually assess heterogeneity. This 
is so that both qualitative and quantitative heterogeneity can be assessed. 
In the current study, results were analyzed as mean differences using a random effects 
model. Analysis was presented in forest plots. Heterogeneity was measured using Tau2, Chi2 and 
the I2 statistics as well as visual inspection of the forest plots. A p-value of <0.05 was considered 
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significant for the overall mean difference. All possible efforts were made to include all available
published and unpublished studies identified in the search strategy. Authors used all resources at 
their disposal to search both published and unpublished results in an attempt to limit the effects 
of possible publication bias. Funnel plots were created but not included as there were too few 
studies and the plots could not be interpreted for bias. When funnel plots contain only a few data 
points, they may appear asymmetrical due to chance alone. With so few included studies, there 
may be publication bias but the funnel plots would likely show this regardless whether it was 
truly present.
3.3  Results  
3.3.1 Systematic Review  
The nine papers (11, 16-24) included in the SR consisted of 7 cross-sectional studies, 1 
prospective cohort study and 1 non-randomized clinical trial. The full study selection process is 
presented in the PRISMA flowchart (Figure 1) and the data extracted from the included papers 
are presented in Table 1. All papers included in the SR used a validated HRQoL assessment tool 
(e.g., the SF 36 or equivalent), but not all tools could be meaningfully combined for the MA. The
standard mean difference could not be used for analysis as each survey used different questions 
and the scales were not comparable, even though they all measured quality of life. Only studies 
applying the generic SF-36 questionnaire were selected in order to give comprehensive 
information and allow for comparisons of study results for both physical and mental health 
domains.  Generic HRQoL was assessed by the SF-36 health survey, which comprises 8 health 
40
domains; physical function, role physical, bodily pain, general health, vitality, social function, 
role-emotion and mental health. All scale scores range from 0-100 with higher scores indicating 
higher health status. 
3.3.2  The Short-Form 36
The SF-36 (The Medical Outcome Study 36-Item Short Form Health Survey) survey was 
developed as a result of the Medical Outcomes Study (MOS) as there was a need in the medical 
field for a tool that was easily administered, well documented and had good psychometric 
properties from a patient’s point of view(29). The MOS was designed for two purposes. The first 
was to determine whether a patient’s outcomes could be explained by differences in a clinician's 
specialty, technical and interpersonal styles and system of care and secondly to develop more 
practical tools for the more regimented monitoring of patient outcomes in medical practice (32). 
The MOS assesses 40 physical and mental health components. From this, 8 domains deemed the 
most important were chosen to be included in the SF-36. The SF-36 is considered a generic 
versus a specific tool as it evaluates health concepts that apply to basic human ideals that apply 
to everyone’s well-being and functional status (32). These domains (e.g., physical and mental 
health domains) are both universally valued and are not age, disease or treatment specific. All of 
the domains for the SF-36 fit within one or more of the following 4 operational definitions: a) 
behavioural functioning, b) perceived well-being c) social and role disability d) personal 
evaluations (perceptions) of health in general(29). Specifically, the 8 included domains of the SF-
36 are: 1) physical functioning, 2) role limitations due to physical health problems 3) bodily pain
4) general health 5) vitality (energy/fatigue) 6) social functioning 7) role limitations due to 
emotional problems 8) mental health (psychological distress and psychological well-being). The 
survey is scored such that a high score indicates optimal health for that domain (i.e., a high score 
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on a pain scale indicates freedom from pain). Once patients have completed the survey there is a 
3-part process to determine the scores. First, 10 items need to be recoded to reflect the low-high 
scoring system. Secondly, a raw scale score is calculated for each domain. Finally, the scores are 
converted to a 0-100 scale (29). Since its creation, the SF-36 has been validated for a wide variety 
of chronic conditions, including obesity (34, 35). Both studies found that the SF-36 is suitable for 
use with an obese population, however there were some limitations noted. The physical and 
mental health summary scores had satisfactory construct validity; however the subscales (i.e., the
individual domains) may require different aggregate groupings for proper interpretation for an 
obese population. The studies recommended the use of an obesity or weight specific HRQoL tool
in conjunction with the SF-36 in order to assess HRQoL in a population living with obesity. 
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Figure 1 PRISMA flow diagram of selection process and included studies
There were three articles not included in the MA. An important article that analysed trends 
and effects of weight loss treatment on HRQoL in severely obese patients over a ten-year period 
was excluded due to the use of different tools (e.g., Current Health Scale, Mood Adjective Check
list, the Hospital Anxiety and Depression Scale, Social Interaction category from the Sickness 
Impact Profile and the Obesity Problems Scale) that could not be combined with the SF-36(29). 
The Swedish Obesity Study (SOS) is a controlled, longitudinal trial of the health effects of 
weight loss in the severely obese. In a SOS study by Karlsson et al. (11) the authors presented data 
on HRQoL at 10 years follow-up post-surgery on 655 of 851 surgically treated patients. This 
study found that HRQoL was associated with the amount of weight lost. Peak improvements in 
the surgical group were observed in the first year of weight loss, whereas the weight regain phase
(mainly between 1-6 year follow up) was accompanied by a gradual decline in HRQoL. The 
period for 6-10 follow-up was characterized by relatively stable observations in both weight and 
HRQoL. At ten years, net gains where noted in all HRQoL domains compared to baseline. 
Comparisons of treatment effects on HRQoL of the surgical versus conventional group after ten 
years showed significantly better outcomes in the surgery group on current health perception, 
social interaction, psychosocial functioning and depression, whereas no significant differences 
were found for overall mood and anxiety. 
The study by Kiewiet et al. (17) measured HRQoL using the Rand-36, a version of the SF-
36(29) six years post-surgery. This paper could not be included as the results were presented as 
graphical data. The authors could not provide the numerical data. In this study, the physical 
functioning domain was the only domain that showed an improvement at follow-up for the 
surgical group versus the comparison group. All other domains (both physical and mental) 
showed no difference between groups. This study also included the Dutch population norms for 
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the Rand-36, and it is interesting to note that there were no significant differences between the 
surgical group and the population norms for 4 out of the 8 domains.
The study by Sanchez-Santos et al. (20) was also excluded. Although the paper focused on 
long term (>5 years) HRQoL post bariatric surgery and compared a surgical group with a control
group, the study examined factors such as depression or stressful life events and how they 
influenced HRQoL. In addition, the tools used to measure HRQoL were not comparable. HRQoL
in this study was assessed at five years post-surgery using the Bariatric Analysis of Reporting 
Outcome System (BAROS) which specifically examines outcomes in the bariatric surgery 
patient (i.e., not administered to the control group), the EQ-5D and a generic tool used to 
measure HRQoL.  
3.3.3  Meta-analysis
The MA comprised 6(16, 18, 19, 21-23) of these 9 studies.  The risk of bias or “quality” of each 
study was assessed and is presented in Table 2. Of the 9 studies included in the SR, 5 were given 
a fair rating and 4 received a good rating. No papers were deemed poor by the reviewers and 
there were no discrepancies between the two reviewers.
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Table 1 Included studies for review and MA
Study Assessed 
Quality
Design Baseline 
characteristics of 
treatment group 
N=population at 
time of follow up
Surgery 
Type
Control Group  Mean
follow  up
time  post-
surgery
HRQOL 
Tool
Raoof et 
al., 2015(23)
Örboro, 
Uppsala,
Sweden
Good Cross-
sectional 
N=485
Baseline:
BMI: 43.5 ± 6.7
Age: not given  
% Female: 84%
Controls were age 
and sex matched.
Average weight loss 
at follow-up
Roux-en-
Y Gastric 
Bypass
N=  1590 ( Control 
Group 1) 
General Swedish 
population 
N=972(Control 
Group 2) 
Scandinavian 
Surgery Registry, 
morbidly obese 
patients accepted to 
bariatric surgery  
11.5 years SF-36
Obesity 
Related 
Problems 
Scale 
Aftab et 
al., 
2014(22)*
Oslo, 
Norway
Good Cross-
sectional
N=177
Baseline:
BMI: 46±5 kg/m2 
Age: 38±9 years
%Female:75%
Average %weight 
loss at follow-up
27.0%± 11.0%
Laparosco
pic Gastric
Bypass
N=288 
Patients on wait list 
at same clinic at time
of follow up
63±5 
months
SF-36 
Obesity 
Related 
Problems 
Scale 
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DeZwaan 
et al. 
2002(16)*
North 
Dakota, 
USA
Fair Cross-
sectional
N=78
Baseline 
BMI: 43.8±5.9 kg/m2
Age: 40.3 (17-61 
years)
%Female:83%
Average BMI at 
follow-up
32.8 kg/m2  (22.7-
49.5) 
Roux-en-
Y Gastric 
Bypass
N= 110 
Pre-operative obese 
patients
Baseline:
BMI: 48.4±8.3 
kg//m2
Age: 39.6(19-62 
years)
%Female: 87%
13.8 years SF-36
Karlsson et
al. 2007(11)
Sweden
Good Prospective 
controlled 
clinical trial
N= 655
Baseline: 
BMI: 41.9±4.2 kg/m2
Age: 47.0± 5.7
Average BMI at 
follow-up
35.3 kg/m2 ± 5.3
Gastric 
banding, 
gastric 
bypass, 
vertical 
gastrectom
y
N= 621 
conventional 
treatment
Baseline: 
BMI:39.9 (4.6) 
kg/m2
Age 48.4±6.7 years
10 years Current 
Health scale, 
Mood 
Adjective 
Check List, 
Hospital  
Anxiety and 
Depression 
scale, 
Sickness 
Impact 
Profile, and 
Obesity 
Related 
Problems 
Scale
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Kiewiet et 
al. 2008(17)
The 
Netherlands
Fair Cross-
sectional
N=59 
Baseline 
BMI: 44.9±5.9 kg/m2
Age: 42.4±9.7
%Female: 93.0%
Average BMI at 
follow-up 
33.3 kg/m2± 6.0
Adjustable
Gastric 
Banding
N=28
Pre-operative 
patients
Baseline
BMI:41.8 ± 3.4 
kg/m2
Age: 39.8±8.5 years
%Female 86.0%
Average BMI at 
follow-up
41.8 ± 3.4 kg/m2
74.7 
months 
RAND 36-
Item Health 
Survey
Kolotkin et
al. 2012(18)*
Utah, 
United 
States
Good Prospective 
cohort
N= 323
Baseline: 
BMI: 47.4±7.7 kg/m2
Age:43.4 10.7
%Female: 84%
Average %EWL at 
follow-up
56.4% ±21.4% 
Gastric 
Bypass
N1=257(Control 
Group 1)
Obese patients on 
wait list **
BMI: 
45.9±(7.9kg/m2
Age: 44.7 10.9
%Female 84%
Average %EWL at 
follow-up
0.3% ±22.2%
N2=272(Control 
Group 2)
 Obese population 
BMI: 43.6±(6.4 
6 years SF-36 
IWQOL-Lite
48
kg/m2
Age 49.7± 10.5 
years
% Female77%
Average %EWL at 
follow-up
0.2% ±23.3%
Laurino 
Neto & 
Herbella. 
2013(19)*
Brazil
Fair Cross 
sectional
N= 50
Baseline 
BMI:51.± 6.3 kg/m2 
Age: 42.0 ±10.8
%Female: 88%
Average BMI at 
follow-up
36.0 ±6.3 kg/m2
Roux-en y
Gastric 
Bypass
N=50 
Obese patients on  
waitlist
Baseline:
BMI: 52.0±8.0 
kg/m2
Age 42.0±11.4 years
%Female 80%
112 months SF-36
Sanchez-
Santos et 
al. 2006(20)
Spain
Fair Cross-
sectional
N=50
Baseline 
BMI: 50.5±9.0kg/ m2
Age: 40.5±9.0
%Female: 90.2%
Roux-en-
Y Gastric 
Bypass
N= 78 
Non-operated 
morbidly obese 
patients
Baseline:
BMI: 47.8±7.0 
kg/m2
Age: 46 0±.8.8 years
%Female:  9% 
>5 years EuroQOL-5D
BAROS 
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Våge et al. 
2003(21)*
Norway
Fair Cross-
sectional
N=20
Baseline:
BMI: 41.0 (33-64 
kg/m2 )
Age:31 (20-51 years)
%Female:100%
Average BMI at 
follow-up
BMI: 33 kg/m2  (23-
75 kg/m2) 
Jejunoileal
Bypass
N1= 1 118  (Control 
Group 1)
Obese patients  
waitlisted for surgery
BMI: 46.6 ± 8.3 
kg/m2
Age : 38.3±  9.8 
years
N2= 80 (Control 
Group 2)
Obese patients 
seeking  treatment
BMI: 48.7 ± 
8.1kg/m2
Age 38.0 (16-70 
years) 
25 years SF-36
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Table 2 Risk of bias assessment*
Study Assembly of 
comparable 
groups
Maintenance of 
comparable 
groups
No important
differential 
loss to follow-
up or overall 
high loss to 
follow up
Measurements: 
equal, reliable, 
valid (includes 
masking of 
outcome 
assessment)
Clear definition
of interventions
All 
important 
outcomes 
considered
Analysis: 
adjustment for 
potential 
confounders
Overall 
assessed 
quality
Raoof et al.
2015(23)
Good Good Fair Good Good Good Good Good 
Aftab et al. 
2014(22)
Fair Fair Good Good Good Good Fair Good
DeZwaan 
et al. 
2002(16)
Good Poor Fair Good Good Good Fair Fair
Karlsson et
al. 2007(11)
Good Good Good Fair Good Good Good Good
Kiewiet et 
al. 2008(17)
Poor Good Fair Good Good Good Fair Fair
Kolotkin et
al. 2012(18)
Good Good Good Good Good Good Good Good
Laurino 
Neto & 
Herbella 
2013(19) 
Fair Fair Fair Fair Fair Fair Fair Fair
Sanchez-
Santos et 
al. 2006(20)
Fair Fair Fair Good Good Poor Fair Fair
Våge et al.  
2003(21)
Poor Fair Fair Good Good Fair Fair Fair
*Risk of bias or ‘quality’ of each study was assessed using the US Preventative Task Force quality rating criteria for assessing the 
quality of nonrandomized studies (27).
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All six studies report some improvements in HRQoL for the surgical patients in the long-
term compared to the obese comparison groups. The physical health scores and total scores 
showed improvements in all studies. Mental health scores had more varied results. Aftab et al. (22) 
study participants showed a significant improvement in all mental health domains of the SF-36 
after five years of follow up compared to a population of patients wait-listed for bariatric 
surgery. DeZwaan et al. (16) found no difference in the mental health domain but there was a 
significant difference favouring the surgical group for all other domains. Kolotkin et al. (18) found 
significant improvements for the surgical group in all domains compared to the control groups 
with the exception of role emotional. Laurino Neto & Herbella (19) found a significant 
improvement in only the vitality score for the surgical group in the long term. Raoof et al. (23) 
showed improvements in the vitality domain for surgical patients over the waitlisted comparison 
group.  Vȧge et al. 2003 found lower social functioning and role emotional scores for their 
surgical group. 
3.3.4  Synthesis of Results 
The results of the MA can be seen in Figures 2a-d (four domains of physical health) and 
Figures 3a-d (four domains of mental health) as forest plots of the domain scores from the SF-36 
survey (29). The z -score generated for each forest plot shows the overall effect of surgery on the 
domain of HRQoL. As the meta analysis looks at the mean difference, the positive value of all 
the z-scores demonstrates that the surgical group showed an improvement in HRQoL when 
compared to the non-surgical control groups, where the p value for the associated z score is 
≤0.05 are considered statistically significant. The z-scores and therefore the overall effect of 
surgery on the HRQoL domains show significant improvement for all groups with the exception 
of role-physical which has a p value = 0.1.  The forest plots favour (p≤0.05) the surgical group 
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for 3 out of 4 physical domain scores and 4 out of 4 mental domain scores. Mean difference and 
95% CI for the physical function, bodily pain and general health were 31.29 (21.37, 41.21), 
12.56 (6.51, 18.61), and 17.54 (6.60, 28.48), respectively. For the mental health scores of 
vitality, social functioning, role emotional and mental health, total scores (mean difference 
(95%CI)) were 18.18(6.50, 23.85), 14.66 (3.34, 25.97), 12.58 (4.06, 21.10) and 6.13 (0.17, 
12.09). Role physical 12.15 (-1.73, 26.02) was not significantly different between the two 
groups. These measures exhibited a fairly high level of heterogeneity (I2≥ 79%) for all domains. 
The statistical tests of heterogeneity show a significant degree of heterogeneity of the results 
from the various studies. Examination of the forest plots show that this is quantitative as opposed
to qualitative heterogeneity. Despite the statistical heterogeneity, the results are similar from 
study to study. The similarity of the results from study to study somewhat mitigates the lack of 
randomization and proper control groups in these studies.
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Figure 2 Forest plots for SF-36 physical domains. Each forest plot represents the non-surgical 
population groups with obesity on the left side and the surgical groups at time of long-term 
follow-up on the right side. The values illustrated in each forest plot are mean differences in 
domain scores between surgery and no surgery. (a) SF-36 physical function domain, (b) SF-36 
role physical domain, (c) SF-36 bodily pain domain, (d) SF-36 general health domain.
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Figure 3 Forest plots for SF-36 mental domains. Each forest plot represents the non-surgical 
population groups with obesity on the left side and the surgical groups at time of long-term 
follow-up on the right side. . The values illustrated in each forest plot are mean differences in 
domain scores between surgery and no surgery. (a) SF-36 vitality domain, (b) SF-36 social 
functioning domain, (c) SF-36 role emotional domain, (d) SF-36 mental health domain.
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3.4 Discussion 
Overall greater improvements in HRQoL (e.g., physical and mental health domains) were
reported in the SR after five years for the surgical group compared to the control group (i.e., 
waitlist bariatric surgery patients, population-based individuals not seeking bariatric surgery). 
However, there were inconsistencies in results (i.e., favouring surgical group, favouring control 
group, and no difference) in the individual physical and mental health domains.  
The MA provides evidence that bariatric surgery significantly improves physical HRQoL
scores, with the exception of only one domain, role physical. The studies by Laurino Neto & 
Herbella (19) and Våge et al. (21) favour no surgery and no effect, respectively, as shown in the MA.
Laurino Neto & Herbella (19) suggest that a decrease in role physical score is related to a lack of 
motivation as age increases in the surgical group. Våge et al. (21) do not address the role physical 
scores between control and surgical groups, but have a 25 year follow up. It is possible that the 
findings are also related to the age of the surgical group as suggested by Laurino Neto & 
Herbella (19).
Contrary to what is reported in the SR, the current MA provides evidence for a significant
improvement in all mental health domains after five years favouring the surgical group 
compared with the controls. This MA documents improvement in mental health at least five 
years after bariatric surgery; a finding that has been inconsistently reported in the general 
literature of HRQoL in individuals undergoing bariatric surgery for the treatment of severe 
obesity(17, 19, 20,22).
The magnitude of improvement in the surgical groups compared to the control groups 
was smaller for the mental health domains compared to the physical health domains, when 
examining the mean differences, but they are all statistically significant with the exception of 
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role physical.  This MA demonstrates that long-term HRQoL significantly improves among 
bariatric surgery patients compared to an obese general population or those waiting for bariatric 
surgery. The similarity of the magnitude and direction of the results in each of the domains from 
study to study speaks very strongly to the validity of these results.  
57
3.5 Chapter 3 References
1. Colquitt JL, Picot J, Loveman E, Clegg AJ. Surgery for obesity. Cochrane Database Syst
Rev2009;15(2):CD003641. doi:10.1002/14651858.CD003641.pub3.
2. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. 
World Health Organization. Report number series:894, 2000.
3. Karmali S, Johnson Stoklossa C, Sharma A, Christiansen S, Cottreau D, Birch 
DW. Bariatric surgery: a primer. Can Fam Phys 2010;56:873-879.
4. Guyatt G, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern 
Med 1993;118:622-629.
5. Dymek MP, LeGrange D, Neven K, Alverdy J. Quality of life and psychosocial 
adjustment in patients after Roux-en-Y gastric bypass: a brief report. Obes 
Surg 2001;11:32-39.
6. van Gemert WG, Adang EMM, Greve JWM, Soeters PB. Quality of life assessment of 
morbidly obese patients: effect of weight-reducing surgery. Am J Clin Nutr 1998;67:197-
201.
7. Karlsson J, Sjöström L, Sullivan M. Swedish obese subjects (SOS): an intervention study 
of obesity: two-year follow-up of health-related quality of life (HRQL) and eating 
behavior after gastric surgery for severe obesity. Int J Obes Relat Metab 
Disord 1998;22:113-126.
8. Nguyen NT, Goldman C, Rosenquist CJ, et al. Laparoscopic versus open gastric bypass: 
a randomized study of outcomes, quality of life, and costs. Ann Surg 2001;234:279-289.
9. O'Brien PE, Dixon JB, Brown W, et al. The laparoscopic adjustable gastric band (Lap-
Band): a prospective study of medium-term effects on weight, health and quality of 
life. Obes Surg 2002;12:652-660.
10. Magro DO, Geloneze B, Delfini R, Pareja BC, Callejas F, Pareja JC. Long-term weight 
regain after gastric bypass: a 5-year prospective study. Obes Surg 2008;18:648-651.
11. Karlsson J, Taft C, Ryden A, Sjostrom L, Sullivan M. Ten-year trends in health-related 
quality of life after surgical and conventional treatment for severe obesity: the SOS 
intervention study. Int J Obes 2007;31:1248-1261.
12. Nickel MK, Loew TH, Bachler E. Change in mental symptoms in extreme obesity 
patients after gastric banding, part II: six-year follow-up. Int J Psychiatry 
Med 2007;37:69-79.
58
13. Helmiö M, Salminen P, Sintonen H, Ovaska J, Victorzon M. A 5-year prospective quality
of life analysis following laparoscopic adjustable gastric banding for morbid 
obesity. Obes Surg 2011;21:1585-1591.
14. Suter M, Donadini A, Romy S, Demartines N, Giusti V. Laparoscopic Roux-en-Y gastric 
bypass: significant long-term weight loss, improvement of obesity-related comorbidities 
and quality of life. Ann Surg 2011;254:267-273.
15. Aasprang A, Andersen JR, Våge V, Kolotkin RL, Natvig GK. Five-year changes in 
health-related quality of life after biliopancreatic diversion with duodenal switch. Obes 
Surg 2013;23:1662-1668.
16. deZwaan M, Lancaster KL, Mitchell JE, et al. Health-related quality of life in morbidly 
obese patients: effect of gastric bypass surgery. Obes Surg 2002;12:773-780.
17. Kiewiet RM, Durian MF, Cuijpers LPLH, Hesp FLEM, van Vliet ACM. Quality of life 
after gastric banding in morbidly obese Dutch patients: long-term follow-up. Obes Res 
Clin Pract 2008;2:151-158.
18. Kolotkin RL, Davidson LE, Crosby RD, Hunt SC, Adams TD. Six-year changes in 
health-related quality of life in gastric bypass patients versus obese comparison 
groups. Surg Obes Relat Dis 2012;8:625-633.
19. Laurino Neto RM, Herbella FAM. Changes in quality of life after short-term and long-
term follow-up of roux-en-Y gastric bypass for morbid obesity. Arg 
Gastroentoerol 2013;50(3):186-190.
20. Sanchez-Santos R, Delarrio MJ, Gonzalez C, et al. Long-term health-related quality of 
life following gastric bypass: influence of depression. Obes Surg 2006;16:580-585.
21. Våge V, Solhaug JH, Viste A, et al. Anxiety, depression and health-related quality of life 
after jejunoileal bypass: a 25-year follow-up study of 20 female patients. Obes 
Surg 2003;3:706-713.
22. Aftab H, Risstad H, Sovik TT, et al. Five-year outcome after gastric bypass for morbid 
obesity in a Norwegian cohort. Surg Obes Relat Dis. 2014;10:71-78.
23. Raoof M, Näslund I, Rask E, et al. Health-related quality-of-life (HRQoL) on average of 
12 years after gastric bypass surgery. Obes Surg 2015;25:1119-1127.
24. Andersen JR, Aasprang A, Karlsen TI, Vage V, Kolotkin Rl. Health related quality of life
after bariatric surgery: a systematic review of prospective long-term studies. Surg Obes 
Relat Dis 2014;2:466-473.
59
25. Warkentin LM, Das D, Majumdar SR, Johnson JA, Padwal RS. The effect of weight loss 
on health-related quality of life: systematic review and meta-analysis of randomized 
trials. Obes Rev 2014;15:169-182.
26. COS Online Research Management Tool. Available from: https://www.refworks.com/. 
RefWorks:Bethesda, MD, 2009. [Accessed  October  10th 2014]
27. Russell P. Harris, Mark Helfand, Steven H. Woolf, Kathleen N. Lohr, Cynthia D. 
Mulrow, Steven M. Teutsch, David Atkins. for the Methods Work Group, Third U.S. 
Preventive Services Task Force. Current Methods of the U.S. Preventive Services Task 
Force A Review of the Process . Am J Prev Med.  2001;  20(3S)
28. RevMan. The Cochrane Collaboration's Review Manager (Vers.5.1). Oxford: The 
Cochrane Collaboration;2011.
29. Ware J, Snow K, Kosinski M, Gandek B. SF-36 Health Survey: Manual and 
Interpretation Guide. Boston: Health Institute, New Eng-land Medical Center; 1993
30. Kontopantelis, E.; Reeves, D. "Performance of statistical methods for meta-analysis when
true study effects are non-normally distributed: A simulation study.". Statistical Methods 
in Medical Research. 2012; 21(4): 409–26.doi:10.1177/0962280210392008. PMID 
21148194. [Accessed November 12th 2014] 
31. Higgins, J., Green, S. (ed.) Cochrane Handbook for Systematic review of interventions. 
Version 5.1.0  Updated March 2011. (chapter 9 &10)
32. Tarlov, A.R, Ware, J.E., Greenfield, S. Nelson E.C, Perrin, E. & Zubkoff M. The Medical
Outcomes Study. An application of methods for monitoring the results of medical care. 
Jama. 1989; 262 (7) 925-30 
33. Ware, J.E. Standards for validating health measures. Definition and Content.  Journal of 
chronic diseases. 1987; 40 473-480
34. Karlsen T.I., Tveita, E.K, Natvig, G.K, Tonstad, S. & Hjelmesaeth, J. Validity of the SF-
36 in patients with morbid obesity. Obes Fact. 2011
35.  Corica, F., Corsonello, A., Apolone, . Lucchetti, M. Melchionda, N., Marchesini, G. 
Construct validity of the short form-36 health survey and its relationship with BMI in 
obese outpatients. Obesity. 2006; 14(8): 1429-37
60
Chapter 4 Summary
 
4.1 Overview
 
The results of this SR and MA show an improvement in both mental and physical scores 
for bariatric patients in the long term. This chapter will discuss the strengths and limitations of 
the SR/MA, the implications of the study findings, future research and overall study conclusions.
4.2 Strengths and Limitations 
There are both strengths and limitations of the current study. The limitations include only
using observational studies as there were no available RCT’s, the limited number of available 
studies, publication bias, how the results were reported, the study populations used, and the wide 
range of HRQoL tools. 
A limitation of this review was that all included papers were observational studies. It is 
difficult to determine whether improvements or declines in quality of life were due to the 
intervention (bariatric surgery) or other confounders. The surgery seeking obese population tends
to be worse off in terms of health compared with other population obese groups (1, 2). This would 
decrease the bias seen between the surgical and comparison groups in the studies for the MA, but
may show differences between studies such as Karlsson et al. (3) who use obese groups seeking 
conventional treatment. This limits the ability to directly compare the MA studies with the 
Karlsson et al. (3), study in the SR.    
There were a small number of comparable studies to use in the MA. This limits the 
usefulness of publication bias tests. The literature search produced a large number of studies 
overall, but many did not use a HRQoL tool that could be used in the MA.  The various HRQoL 
surveys used across studies measured different aspects of quality of life, making it difficult to use
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the standard mean difference to compare different surveys. The SF-36 was the most frequently 
used measure in our review. However, as a generic measure of HRQoL, it may not be the most 
sensitive questionnaire to examine HRQoL in bariatric surgery patients (4). 
Publication bias exists when the findings of a study influence whether it is published or 
not. In research, negative or “non” results often go unpublished but may include important 
findings. Publication bias can occur in cases like this when only the positive outcomes are 
reported which can lead to an information bias. It may also occur in reverse when positive results
are not published for a certain reason (5). In a MA, funnel plots are a graphical way of assessing 
publication bias.  A funnel plot is a scatter plot showing the intervention effect estimates from 
each study against a measure of each study’s size or precision. The horizontal axis commonly 
represents the effect estimates and the vertical assess represents the study size on the vertical 
axis.  Without bias present, the plot should resemble an inverted “funnel” with smaller studies 
evenly distributed across the horizontal (effect) axis but near the bottom of the vertical (study 
size) axis. Larger studies will be clustered closer to the center of the horizontal axis but higher up
on the vertical axis. Visual assessment of funnel plots can be subjective and some argue 
minimally useful (5). It is also hard to assess when there are a limited number of studies as the 
funnel shape will not be visually apparent with only a few data points on the plot. In this MA, a 
funnel plot was generated but not included as there were only 9 studies and the plot was not 
useful in showing any kind of trend in publication distribution. The data points were too sparse 
to show either a definite symmetrical or asymetrical shape limiting interpretation of results in 
terms of publication bias. It is possible that this study suffers from publication bias which is a 
limitation of the study and the results. 
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The study results were presented in a variety of formats. In most cases authors were able 
to be reached and appropriate data obtained directly from the original research team. Laurino 
Neto & Herbella(6) reported their results using median and IQR and the results which seemed a 
questionable choice on the part of the authors based on the recommended form of reporting 
suggested by the SF-36 instructions(7). The results were converted to mean and standard deviation
using an excel conversion file, but their original data was presented in a format different from the
usual format for SF-36 results, which could impact the results of the MA. The results shifted to 
favouring surgery when the Laurino Neto & Herbella (6) study was removed for the role physical 
domain in a sensitivity analysis. 
The use of historical subjects versus contemporaneous comparison groups may also cause
a bias in the results. The wait listed comparison groups were not followed prospectively as were 
the surgical groups. This may cause differences in baseline results between the groups as well as 
impact group scores on the HRQoL surveys. The comparison groups for the included studies did 
not come from randomized control trials therefore there is the possibility that the control groups 
were inherently different at baseline than the groups seeking surgery. Should this be the case, 
there may be a bias in the comparison of the 2 groups.
 The limited number of studies using the same standardized and validated HRQoL tools 
hindered the degree to which studies could be meaningfully compared. There is no official “gold 
standard” for HRQoL measurements (8, 9). Of the 9 studies that met inclusion criteria for the SR, 9
different HRQoL tools were used. The majority of these tools were used in a single study, the 
SOS, which is the largest and most comprehensive of the review studies, using multiple generic 
and obesity specific tools(3). The studies that helped validate the SF-36 for use with obese 
populations (10, 11) make the observation that a weight specific and generic tool combined would 
63
give the most accurate view of HRQoL.  On closer examination of the PRISMA flowchart, there 
are a number of studies eliminated due to the type of HRQoL tool. This generally meant that a 
formal tool was not used, or that the tool was not validated. There may be studies that have 
comparable study populations and study design but because of the tool selected the HRQoL 
results cannot be used in comparisons.   The SF-36 has been validated for use in a population 
with obesity, but there are some limitations that have been raised in other studies (10, 11) mainly 
surrounding the discrepancies amongst the subscales versus the component scores. The majority 
of papers did not calculate the physical or MCSs and therefore they were not compared in the 
MA. These scores may provide additional insights in to the HRQoL of patients. 
The strengths include the thorough nature of the literature review as well as the 
homogeneity in the direction of the results for the forest plots in the meta-analyses. The strength 
of the MA comes from the large qualitative homogeneity of the results across the forest plots. 
The statistical heterogeneity was fairly high in all studies, but through visual assessment of the 
forest plots, the results were incredibly similar and had the same directionality, despite having a 
large range in population size and time to follow up.       
4.3 Implications of the Current Study Findings
These results are important for patients, health professionals and decision makers. For 
patients, they provide comfort that in the long term, bariatric surgery has a positive impact on 
general HRQoL as it relates to physical and mental health domains. For health professionals the 
study provides evidence that an intervention to treat severe obesity that results in short term 
improvements in HRQoL is sustained in the long term.  For decision makers, given the increases 
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in the prevalence of severe obesity and the provision of bariatric surgery as a treatment, these 
findings help to inform evidence-based care in the area of bariatric care. 
4.4  Future Research
The importance and relevance of future research on the long-term HRQoL of bariatric 
surgery patients will increase as the number of bariatric surgeries continues to increase. 
Standardization of a preferred reporting method for HRQoL for both obese and bariatric patients 
is essential for future research. Without a standard method of HRQoL reporting, the presentation 
of results can be varied and make it difficult to compare across studies.
It is also important to study the relation between the primary and other secondary outcomes of 
bariatric surgery with HRQoL in the long term. There is a trend toward at least a partial regain of
weight in the long term for patients’ post-bariatric surgery. It is important to understand the 
correlation of comorbid conditions and weight gain as it pertains to a maintenance in 
improvement in quality of life.  
 
4.5 Conclusions 
The main aim of this thesis was two-fold: first to conduct a SR in order to assess the 
quality of evidence and effectiveness of bariatric surgery on HRQoL ≥ 5 years in patients ≥18 
years compared to non-surgical control groups and second to conduct a MA of appropriate 
studies. The SR found inconsistent results for long-term improvements in physical and mental 
health. In contrast, the MA found significant improvements in these domains ≥ 5 years after 
bariatric surgery. These study findings provide evidence for a substantial and significant 
improvement in physical and mental health favoring the surgical group compared with controls 
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spanning 5 to 25 years after surgery, an important finding for patients, clinicians and decision-
makers. 
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Appendix A
The Short Form (SF)-36
SF-36 QUESTIONNAIRE
Name:____________________ Ref. Dr:___________________ Date: _______
ID#: _______________ Age: _______ Gender: M / F
Please answer the 36 questions of the Health Survey completely, honestly, and without 
interruptions.
GENERAL HEALTH:
In general, would you say your health is:
Excellent Very Good Good Fair Poor
Compared to one year ago, how would you rate your health in general now?
Much better now than one year ago
Somewhat better now than one year ago
About the same
Somewhat worse now than one year ago
Much worse than one year ago
LIMITATIONS OF ACTIVITIES:
The following items are about activities you might do during a typical day. Does your health 
now limit you in these
activities? If so, how much?
Vigorous activities, such as running, lifting heavy objects, participating in strenuous sports.
Yes, Limited a lot Yes, Limited a Little No, Not Limited at all
Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing 
golf
Yes, Limited a Lot Yes, Limited a Little No, Not Limited at all
Lifting or carrying groceries
Yes, Limited a Lot Yes, Limited a Little No, Not Limited at all
Climbing several flights of stairs
Yes, Limited a Lot Yes, Limited a Little No, Not Limited at all
Climbing one flight of stairs
Yes, Limited a Lot Yes, Limited a Little No, Not Limited at all
Bending, kneeling, or stooping
Yes, Limited a Lot Yes, Limited a Little No, Not Limited at all
Walking more than a mile
Yes, Limited a Lot Yes, Limited a Little No, Not Limited at all
Walking several blocks
Yes, Limited a Lot Yes, Limited a Little No, Not Limited at all
Walking one block
Yes, Limited a Lot Yes, Limited a Little No, Not Limited at all
Bathing or dressing yourself
Yes, Limited a Lot Yes, Limited a Little No, Not Limited at all
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PHYSICAL HEALTH PROBLEMS:
During the past 4 weeks, have you had any of the following problems with your work or other 
regular daily activities as
a result of your physical health?
Cut down the amount of time you spent on work or other activities
Yes No
Accomplished less than you would like
Yes No
Were limited in the kind of work or other activities
Yes No
Had difficulty performing the work or other activities (for example, it took extra effort)
Yes No
EMOTIONAL HEALTH PROBLEMS:
During the past 4 weeks, have you had any of the following problems with your work or other 
regular daily activities as
a result of any emotional problems (such as feeling depressed or anxious)?
Cut down the amount of time you spent on work or other activities
Yes No
Accomplished less than you would like
Yes No
Didn't do work or other activities as carefully as usual
Yes No
SOCIAL ACTIVITIES:
Emotional problems interfered with your normal social activities with family, friends, 
neighbors, or groups?
Not at all Slightly Moderately Severe Very Severe
PAIN:
How much bodily pain have you had during the past 4 weeks?
None Very Mild Mild Moderate Severe Very Severe
During the past 4 weeks, how much did pain interfere with your normal work (including 
both work outside the
home and housework)?
Not at all A little bit Moderately Quite a bit Extremely
ENERGY AND EMOTIONS:
These questions are about how you feel and how things have been with you during the last 4 
weeks. For each
question, please give the answer that comes closest to the way you have been feeling.
Did you feel full of pep?
All of the time
Most of the time
A good Bit of the Time
Some of the time
A little bit of the time
None of the Time
Have you been a very nervous person?
All of the time
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Most of the time
A good Bit of the Time
Some of the time
A little bit of the time
None of the Time
Have you felt so down in the dumps that nothing could cheer you up?
All of the time
Most of the time
A good Bit of the Time
Some of the time
A little bit of the time
None of the Time
Have you felt calm and peaceful?
All of the time
Most of the time
A good Bit of the Time
Some of the time
A little bit of the time
None of the Time
Did you have a lot of energy?
All of the time
Most of the time
A good Bit of the Time
Some of the time
A little bit of the time
None of the Time
Have you felt downhearted and blue?
All of the time
Most of the time
A good Bit of the Time
Some of the time
A little bit of the time
None of the Time
Did you feel worn out?
All of the time
Most of the time
A good Bit of the Time
Some of the time
A little bit of the time
None of the Time
Have you been a happy person?
All of the time
Most of the time
A good Bit of the Time
Some of the time
A little bit of the time
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None of the Time
Did you feel tired?
All of the time
Most of the time
A good Bit of the Time
Some of the time
A little bit of the time
None of the Time
SOCIAL ACTIVITIES:
During the past 4 weeks, how much of the time has your physical health or emotional 
problems interfered with
your social activities (like visiting with friends, relatives, etc.)?
All of the time
Most of the time
Some of the time
A little bit of the time
None of the Time
GENERAL HEALTH:
How true or false is each of the following statements for you?
I seem to get sick a little easier than other people
Definitely true Mostly true Don't know Mostly false Definitely false
I am as healthy as anybody I know
Definitely true Mostly true Don't know Mostly false Definitely false
I expect my health to get worse
Definitely true Mostly true Don't know Mostly false Definitely false
My health is excellent
Definitely true Mostly true Don't know Mostly false Definitely false
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Appendix B
USPSTF Randomized Controlled Trials (RCTs) and Cohort Studies
Criteria
 Initial assembly of comparable groups: RCTs—adequate randomization, including 
concealment and whether potential confounders were distributed equally among 
groups; cohort studies—consideration of potential confounders with either restriction or 
measurement for adjustment in the analysis; consideration of inception cohorts
 Maintenance of comparable groups (includes attrition, cross-overs, adherence, 
contamination)
 Important differential loss to follow-up or overall high loss to follow-up
 Measurements: equal, reliable, and valid (includes masking of outcome assessment)
 Clear definition of interventions
 Important outcomes considered
 Analysis: adjustment for potential confounders for cohort studies, or intention-to-treat 
analysis for RCTs (i.e. analysis in which all participants in a trial are analyzed according 
to the intervention to which they were allocated, regardless of whether or not they 
completed the intervention)
Definition of ratings based on above criteria
Good: Meets all criteria: Comparable groups are assembled initially and maintained throughout 
the study (follow-up at least 80 percent); reliable and valid measurement instruments are 
used and applied equally to the groups; interventions are spelled out clearly; important 
outcomes are considered; and appropriate attention to confounders in analysis.
Fair: Studies will be graded “fair” if any or all of the following problems occur, without the 
important limitations noted in the “poor” category below: Generally comparable groups 
are assembled initially but some question remains whether some (although not major) 
differences occurred in follow-up; measurement instruments are acceptable (although not 
the best) and generally applied equally; some but not all important outcomes are 
considered; and some but not all potential confounders are accounted for.
Poor: Studies will be graded “poor” if any of the following major limitations exists: Groups 
assembled initially are not close to being comparable or maintained throughout the study; 
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unreliable or invalid measurement instruments are used or not applied at all equally among
groups (including not masking outcome assessment); and key confounders are given little 
or no attention.
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